BRWS1
MCID: BRT038
MIFTS: 41

Baraitser-Winter Syndrome 1 (BRWS1)

Categories: Genetic diseases, Rare diseases

Aliases & Classifications for Baraitser-Winter Syndrome 1

MalaCards integrated aliases for Baraitser-Winter Syndrome 1:

Name: Baraitser-Winter Syndrome 1 57 74 29 13 6
Fryns-Aftimos Syndrome 57 74 29 72
Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation 57 74 72
Cerebrofrontofacial Syndrome 57 74 72
Pachygyria, Mental Retardation, Epilepsy, and Characteristic Facies 57 74
Mental Retardation with Epilepsy and Characteristic Facies 57 74
Cerebrooculofacial Lymphatic Syndrome 57 74
Chromosome 7p22 Deletion Syndrome 57 74
Brws1 57 74
Cofls 57 74
Cerebrooculofacial Lymphatic Syndrome; Cofls 57
Baraitser-Winter Syndrome, Type 1 40
Hypertelorism 44

Characteristics:

OMIM:

57
Inheritance:
autosomal dominant

Miscellaneous:
highly variable phenotype
some patients have a deletion of chromosome 7p22.1, consistent with a contiguous gene deletion syndrome


HPO:

32
baraitser-winter syndrome 1:
Inheritance autosomal dominant inheritance autosomal recessive inheritance


Classifications:



External Ids:

MedGen 42 C1855722
UMLS 72 C1837819 C1853623 C1855722

Summaries for Baraitser-Winter Syndrome 1

OMIM : 57 BRWS is a rare developmental phenotype characterized by the combination of hypertelorism, broad nose with large tip and prominent root, congenital nonmyopathic ptosis, ridged metopic suture, arched eyebrows, iris or retinal coloboma, sensorineural deafness, shoulder girdle muscle bulk and progressive joint stiffness, and pachygyria with anteroposterior severity gradient, rarely lissencephaly or neuronal heterotopia. Cleft lip and palate, hallux duplex, congenital heart defects and renal tract anomalies are seen in some cases. Microcephaly may develop with time. Early muscular involvement, occasionally with congenital arthrogryposis, may be present. Intellectual disability and epilepsy are variable in severity and largely correlate with central nervous system anomalies (summary by Verloes et al., 2015). Di Donato et al. (2014) and Verloes et al. (2015) suggested that BRWS, Fryns-Aftimos syndrome, and cerebrofrontofacial syndrome represent the same clinical entity. The phenotype is highly variable (summary by Cuvertino et al., 2017). (243310)

MalaCards based summary : Baraitser-Winter Syndrome 1, also known as fryns-aftimos syndrome, is related to hypertelorism and hypertelorism, teebi type, and has symptoms including seizures An important gene associated with Baraitser-Winter Syndrome 1 is ACTB (Actin Beta). The drugs Simvastatin and tannic acid have been mentioned in the context of this disorder. Affiliated tissues include brain, heart and myeloid, and related phenotypes are highly arched eyebrow and retrognathia

UniProtKB/Swiss-Prot : 74 Baraitser-Winter syndrome 1: A rare developmental disorder characterized by the combination of congenital ptosis, high-arched eyebrows, hypertelorism, ocular colobomata, and a brain malformation consisting of anterior- predominant lissencephaly. Other typical features include postnatal short stature and microcephaly, intellectual disability, seizures, and hearing loss.

Related Diseases for Baraitser-Winter Syndrome 1

Diseases in the Baraitser-Winter Syndrome family:

Baraitser-Winter Syndrome 1 Baraitser-Winter Syndrome 2

Diseases related to Baraitser-Winter Syndrome 1 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 452)
# Related Disease Score Top Affiliating Genes
1 hypertelorism 12.7
2 hypertelorism, teebi type 12.6
3 hypertelorism, microtia, facial clefting syndrome 12.6
4 intellectual developmental disorder with hypertelorism and distinctive facies 12.4
5 hypertelorism, preauricular sinus, punctal pits, and deafness 12.4
6 intellectual deficit - short stature - hypertelorism 12.4
7 hypertelorism and tetralogy of fallot 12.3
8 hypertelorism and other facial dysmorphism, brachydactyly, genital abnormalities, mental retardation, and recurrent inflammatory episodes 12.3
9 donnai-barrow syndrome 12.1
10 intellectual disability-short stature-hypertelorism syndrome 12.1
11 corpus callosum agenesis-macrocephaly-hypertelorism syndrome 12.1
12 opitz-gbbb syndrome 12.1
13 opitz gbbb syndrome, type ii 12.1
14 opitz gbbb syndrome, type i 12.0
15 baraitser-winter syndrome 12.0
16 hamamy syndrome 12.0
17 elsahy-waters syndrome 11.9
18 acrofrontofacionasal dysostosis 2 11.9
19 gastrocutaneous syndrome 11.9
20 saethre-chotzen syndrome 11.9
21 hartsfield syndrome 11.8
22 seaver cassidy syndrome 11.8
23 leopard syndrome 11.7
24 craniofacial-deafness-hand syndrome 11.7
25 mandibulofacial dysostosis with macroblepharon and macrostomia 11.6
26 wolf-hirschhorn syndrome 11.6
27 frontonasal dysplasia 1 11.5
28 craniofrontonasal syndrome 11.5
29 axenfeld-rieger anomaly with partially absent eye muscles, distinctive face, hydrocephaly, and skeletal abnormalities 11.4
30 external auditory canal, bilateral atresia of, with congenital vertical talus 11.4
31 bagatelle cassidy syndrome 11.4
32 santos mateus leal syndrome 11.4
33 sotos syndrome 1 11.4
34 3mc syndrome 1 11.4
35 acromelic frontonasal dysostosis 11.4
36 noonan syndrome 1 11.3
37 oculodentodigital dysplasia 11.3
38 3mc syndrome 2 11.3
39 opitz-kaveggia syndrome 11.3
40 telecanthus 11.3
41 gillessen-kaesbach-nishimura syndrome 11.2
42 krauss herman holmes syndrome 11.2
43 greig cephalopolysyndactyly syndrome 11.2
44 apert syndrome 11.2
45 lubs x-linked mental retardation syndrome 11.2
46 axenfeld-rieger syndrome, type 3 11.2
47 bohring-opitz syndrome 11.2
48 frontonasal dysplasia 2 11.2
49 baraitser-winter syndrome 2 11.2
50 diamond-blackfan anemia 11.2

Graphical network of the top 20 diseases related to Baraitser-Winter Syndrome 1:



Diseases related to Baraitser-Winter Syndrome 1

Symptoms & Phenotypes for Baraitser-Winter Syndrome 1

Human phenotypes related to Baraitser-Winter Syndrome 1:

32 (show all 44)
# Description HPO Frequency HPO Source Accession
1 highly arched eyebrow 32 occasional (7.5%) HP:0002553
2 retrognathia 32 occasional (7.5%) HP:0000278
3 ventriculomegaly 32 occasional (7.5%) HP:0002119
4 microphthalmia 32 occasional (7.5%) HP:0000568
5 cleft upper lip 32 occasional (7.5%) HP:0000204
6 oral cleft 32 occasional (7.5%) HP:0000202
7 duplication of phalanx of hallux 32 occasional (7.5%) HP:0010066
8 hypertelorism 32 HP:0000316
9 low-set ears 32 HP:0000369
10 short neck 32 HP:0000470
11 agenesis of corpus callosum 32 HP:0001274
12 ptosis 32 HP:0000508
13 intellectual disability 32 HP:0001249
14 seizures 32 HP:0001250
15 muscular hypotonia 32 HP:0001252
16 failure to thrive 32 HP:0001508
17 global developmental delay 32 HP:0001263
18 wide nasal bridge 32 HP:0000431
19 short nose 32 HP:0003196
20 microcephaly 32 HP:0000252
21 sensorineural hearing impairment 32 HP:0000407
22 anteverted nares 32 HP:0000463
23 short stature 32 HP:0004322
24 abnormality of metabolism/homeostasis 32 HP:0001939
25 long philtrum 32 HP:0000343
26 generalized hypotonia 32 HP:0001290
27 patent ductus arteriosus 32 HP:0001643
28 epicanthus 32 HP:0000286
29 cryptorchidism 32 HP:0000028
30 postnatal growth retardation 32 HP:0008897
31 low posterior hairline 32 HP:0002162
32 bicuspid aortic valve 32 HP:0001647
33 chorioretinal coloboma 32 HP:0000567
34 wide mouth 32 HP:0000154
35 trigonocephaly 32 HP:0000243
36 micropenis 32 HP:0000054
37 overfolded helix 32 HP:0000396
38 iris coloboma 32 HP:0000612
39 thin upper lip vermilion 32 HP:0000219
40 pointed chin 32 HP:0000307
41 midface retrusion 32 HP:0011800
42 long palpebral fissure 32 HP:0000637
43 pachygyria 32 HP:0001302
44 aortic valve stenosis 32 HP:0001650

Symptoms via clinical synopsis from OMIM:

57
Head And Neck Eyes:
hypertelorism
ptosis
chorioretinal coloboma
prominent epicanthal folds
microphthalmia (rare)
more
Head And Neck Neck:
short neck

Growth Other:
failure to thrive
pre- and postnatal growth retardation

Head And Neck Head:
microcephaly
trigonocephaly
metopic ridging

Head And Neck Face:
long philtrum
pointed chin
midface hypoplasia
prominent/full/wide cheeks
retrognathia (in some patients)

Genitourinary Internal Genitalia Male:
cryptorchidism

Head And Neck Mouth:
thin upper lip
large mouth
thick/prominent/everted lower lip
cleft lip/palate (in some patients)

Genitourinary External Genitalia Male:
small penis

Genitourinary Kidneys:
renal abnormalities

Skeletal Limbs:
limited extension of knees and elbows (in some patients)

Laboratory Abnormalities:
chromosome inversion - inv2(p12q14) in 2 patients

Head And Neck Ears:
low-set ears
hearing loss, sensorineural (in some patients)
abnormally shaped ears
overfolded helices

Neurologic Central Nervous System:
intellectual disability
developmental delay
hypotonia
seizures (in some patients)
enlarged ventricles (in some patients)
more
Head And Neck Nose:
short nose
broad nasal bridge
upturned nose
large, squared nose tip
prominent nasal root on profile

Growth Height:
short stature
height in childhood <5th percentile

Cardiovascular Vascular:
patent ductus arteriosus

Cardiovascular Heart:
bicuspid aortic valve
aortic stenosis

Skin Nails Hair Hair:
low posterior hair line

Growth Weight:
weight in childhood <5th percentile

Skeletal Spine:
kyphosis/scoliosis (in some patients)
pectus (in some patients)

Skeletal Feet:
duplicated hallux (rare)

Clinical features from OMIM:

243310

UMLS symptoms related to Baraitser-Winter Syndrome 1:


seizures

Drugs & Therapeutics for Baraitser-Winter Syndrome 1

Drugs for Baraitser-Winter Syndrome 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Simvastatin Approved Phase 2 79902-63-9 54454
2
tannic acid Approved Phase 1, Phase 2 1401-55-4
3
Benzocaine Approved, Investigational Phase 1, Phase 2 94-09-7, 1994-09-7 2337
4 Lipid Regulating Agents Phase 2
5 Hydroxymethylglutaryl-CoA Reductase Inhibitors Phase 2
6 Hypolipidemic Agents Phase 2
7 Antimetabolites Phase 2
8 Anticholesteremic Agents Phase 2
9 Antioxidants Phase 2
10 Protective Agents Phase 2
11 Anesthetics Phase 2
12 Gastrointestinal Agents Phase 1, Phase 2
13 Cholic Acids Phase 1, Phase 2
14 Phytosterol

Interventional clinical trials:

(show all 14)
# Name Status NCT ID Phase Drugs
1 The Effects of Dietary Cholesterol in the Smith-Lemli-Opitz Syndrome Unknown status NCT00004347 Phase 2
2 Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome Completed NCT00272844 Phase 1, Phase 2 crystalline cholesterol oil-based suspension
3 Short-Term Behavioral Effects of Cholesterol Therapy in Smith-Lemli-Opitz Syndrome Completed NCT00114634 Phase 2
4 Investigation of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome Completed NCT00064792 Phase 2 Simvastatin Susp.;OraPlus
5 Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS) Recruiting NCT01773278 Phase 2 Antioxidants;Cholesterol
6 Smith-Lemli-Opitz Syndrome: A Pilot Study of Cholic Acid Supplementation Not yet recruiting NCT03720990 Phase 1, Phase 2 Cholic Acid
7 Smith-Lemli Opitz Syndrome: A Clinical Investigation of the Effect of Simvastatin in Patients Receiving Cholesterol Supplementation Unknown status NCT01434745 Simvastatin
8 Carrier Frequency and Incidence of Smith-Lemli-Opitz Syndrome in African Americans Completed NCT00017732
9 The Feasibility of Screening for Smith-Lemli-Opitz Syndrome Completed NCT00070850
10 Bohring-Opitz Syndrome and ASXL-Related Phenotypes Registry Recruiting NCT03303716
11 Identification of Mutations That Lead to Craniometaphyseal Dysplasia in Families and Isolated Cases and Studies of Cellular and Molecular Mechanisms Recruiting NCT01630460
12 Clinical and Basic Investigations Into Smith-Lemli-Opitz Syndrome Recruiting NCT00001721
13 Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving Cholesterol Supplementation Terminated NCT01356420
14 Smith-Lemli-Opitz Syndrome: A Longitudinal Clinical Study of Patients Receiving Cholesterol Supplementation Withdrawn NCT01413425

Search NIH Clinical Center for Baraitser-Winter Syndrome 1

Cochrane evidence based reviews: hypertelorism

Genetic Tests for Baraitser-Winter Syndrome 1

Genetic tests related to Baraitser-Winter Syndrome 1:

# Genetic test Affiliating Genes
1 Baraitser-Winter Syndrome 1 29 ACTB
2 Fryns-Aftimos Syndrome 29

Anatomical Context for Baraitser-Winter Syndrome 1

MalaCards organs/tissues related to Baraitser-Winter Syndrome 1:

41
Brain, Heart, Myeloid

Publications for Baraitser-Winter Syndrome 1

Articles related to Baraitser-Winter Syndrome 1:

(show all 26)
# Title Authors PMID Year
1
Severe forms of Baraitser-Winter syndrome are caused by ACTB mutations rather than ACTG1 mutations. 38 8 71
23756437 2014
2
ACTB Loss-of-Function Mutations Result in a Pleiotropic Developmental Disorder. 8 71
29220674 2017
3
Baraitser-Winter cerebrofrontofacial syndrome: delineation of the spectrum in 42 cases. 8 71
25052316 2015
4
Functional analysis of a de novo ACTB mutation in a patient with atypical Baraitser-Winter syndrome. 8 71
23649928 2013
5
De novo mutations in the actin genes ACTB and ACTG1 cause Baraitser-Winter syndrome. 8 71
22366783 2012
6
A new syndrome with craniofacial and skeletal dysmorphisms and developmental delay. 8 71
11311002 2001
7
New MR/MCA syndrome with distinct facial appearance and general habitus, broad and webbed neck, hypoplastic inverted nipples, epilepsy, and pachygyria of the frontal lobes. 8 71
10928857 2000
8
Frontonasal dysplasia, macroblepharon, eyelid colobomas, ear anomalies, macrostomia, mental retardation, and CNS structural anomalies. A new syndrome? 8 71
10327243 1999
9
Acrocallosal syndrome: report of a Brazilian girl. 8 71
1415343 1992
10
7p22.1 microdeletions involving ACTB associated with developmental delay, short stature, and microcephaly. 38 8
27633570 2016
11
Severe epilepsy and pachygyria associated with peculiar facial traits characterize Fryns-Aftimos syndrome. 38 8
15794188 2005
12
Baraitser-Winter Cerebrofrontofacial Syndrome 71
26583190 2015
13
A mutation of beta -actin that alters depolymerization dynamics is associated with autosomal dominant developmental malformations, deafness, and dystonia. 8
16685646 2006
14
Cerebro-fronto-facial syndrome: report of a further case. 8
15057132 2004
15
Cerebro-oculo-facial-lymphatic syndrome. 8
12702162 2003
16
Aggregation of actin and cofilin in identical twins with juvenile-onset dystonia. 8
12325076 2002
17
Cerebro-fronto-facial syndrome: three types? 8
11311000 2001
18
Frontonasal dysplasia, macroblepharon, eyelid colobomas, ear anomalies, macrostomia, mental retardation and CNS structural anomalies: defining the phenotype. 8
11311001 2001
19
Frontonasal dysplasia, macroblepharon, eyelid colobomas, ear anomalies, macrostomia, mental retardation, and CNS structural anomalies: another observation. 8
10649800 2000
20
Previously apparently undescribed syndrome: shallow orbits, ptosis, coloboma, trigonocephaly, gyral malformations, and mental and growth retardation. 8
7545868 1995
21
Iris coloboma, ptosis, hypertelorism, and mental retardation: a new syndrome possibly localised on chromosome 2. 8
1865474 1991
22
Iris coloboma, ptosis, hypertelorism, and mental retardation: a new syndrome. 8
3351890 1988
23
Abnormal childhood phenotypes associated with the same balanced chromosome rearrangements as in the parents. 8
457136 1979
24
Exome sequencing in syndromic brain malformations identifies novel mutations in ACTB, and SLC9A6, and suggests BAZ1A as a new candidate gene. 38
29388391 2018
25
Acute myeloid leukemia in Baraitser-Winter cerebrofrontofacial syndrome. 38
27868373 2017
26
Fryns-Aftimos syndrome with milder clinical manifestations. 38
19449464 2009

Variations for Baraitser-Winter Syndrome 1

ClinVar genetic disease variations for Baraitser-Winter Syndrome 1:

6 (show top 50) (show all 53)
# Gene Variation Type Significance SNP ID GRCh37 Pos GRCh38 Pos
1 ACTB NM_001101.5(ACTB): c.351G> T (p.Glu117Asp) single nucleotide variant Pathogenic rs765265404 7:5568804-5568804 7:5529173-5529173
2 ACTB NM_001101.5(ACTB): c.350A> T (p.Glu117Val) single nucleotide variant Pathogenic rs1554329516 7:5568805-5568805 7:5529174-5529174
3 ACTB NM_001101.5(ACTB): c.1117A> T (p.Lys373Ter) single nucleotide variant Pathogenic rs1554329068 7:5567390-5567390 7:5527759-5527759
4 ACTB NM_001101.5(ACTB): c.329del (p.Leu110fs) deletion Pathogenic rs1554329523 7:5568826-5568826 7:5529195-5529195
5 ACTB NM_001101.5(ACTB): c.193C> G (p.Leu65Val) single nucleotide variant Pathogenic rs281875332 7:5568962-5568962 7:5529331-5529331
6 ACTB NM_001101.5(ACTB): c.34A> G (p.Asn12Asp) single nucleotide variant Pathogenic rs281875331 7:5569255-5569255 7:5529624-5529624
7 ACTB NM_001101.5(ACTB): c.349G> A (p.Glu117Lys) single nucleotide variant Pathogenic rs397515470 7:5568806-5568806 7:5529175-5529175
8 ACTB NM_001101.5(ACTB): c.34A> C (p.Asn12His) single nucleotide variant Pathogenic rs281875331 7:5569255-5569255 7:5529624-5529624
9 ACTB NM_001101.5(ACTB): c.193C> T (p.Leu65Phe) single nucleotide variant Pathogenic rs281875332 7:5568962-5568962 7:5529331-5529331
10 ACTB NM_001101.5(ACTB): c.209C> T (p.Pro70Leu) single nucleotide variant Pathogenic rs587779769 7:5568946-5568946 7:5529315-5529315
11 ACTB NM_001101.5(ACTB): c.356T> C (p.Met119Thr) single nucleotide variant Pathogenic rs587779773 7:5568799-5568799 7:5529168-5529168
12 ACTB NM_001101.5(ACTB): c.359C> T (p.Thr120Ile) single nucleotide variant Pathogenic rs587779774 7:5568796-5568796 7:5529165-5529165
13 ACTB NM_001101.5(ACTB): c.446C> T (p.Thr149Ile) single nucleotide variant Pathogenic rs587779775 7:5568268-5568268 7:5528637-5528637
14 ACTB NM_001101.5(ACTB): c.586C> A (p.Arg196Ser) single nucleotide variant Pathogenic rs281875333 7:5568128-5568128 7:5528497-5528497
15 ACTB NM_001101.5(ACTB): c.611C> G (p.Ala204Gly) single nucleotide variant Pathogenic rs587779776 7:5568103-5568103 7:5528472-5528472
16 ACTB NM_001101.5(ACTB): c.587G> A (p.Arg196His) single nucleotide variant Pathogenic rs281875334 7:5568127-5568127 7:5528496-5528496
17 ACTB NM_001101.5(ACTB): c.1090G> A (p.Glu364Lys) single nucleotide variant Pathogenic rs368352689 7:5567417-5567417 7:5527786-5527786
18 ACTB NM_001101.5(ACTB): c.802G> C (p.Gly268Arg) single nucleotide variant Pathogenic rs1554329269 7:5567912-5567912 7:5528281-5528281
19 ACTB NM_001101.5(ACTB): c.547C> T (p.Arg183Trp) single nucleotide variant Pathogenic/Likely pathogenic rs104894003 7:5568167-5568167 7:5528536-5528536
20 ACTB NM_001101.5(ACTB): c.625G> A (p.Val209Met) single nucleotide variant Pathogenic/Likely pathogenic rs587779777 7:5568089-5568089 7:5528458-5528458
21 ACTB NM_001101.5(ACTB): c.220G> A (p.Gly74Ser) single nucleotide variant Likely pathogenic rs587779770 7:5568935-5568935 7:5529304-5529304
22 ACTB NM_001101.5(ACTB): c.224T> C (p.Ile75Thr) single nucleotide variant Likely pathogenic rs587779771 7:5568931-5568931 7:5529300-5529300
23 ACTB NM_001101.5(ACTB): c.217C> T (p.His73Tyr) single nucleotide variant Likely pathogenic rs786205585 7:5568938-5568938 7:5529307-5529307
24 ACTB NM_001101.5(ACTB): c.113C> T (p.Pro38Leu) single nucleotide variant Likely pathogenic rs1554329646 7:5569176-5569176 7:5529545-5529545
25 ACTB NM_001101.5(ACTB): c.269_271del (p.Phe90del) deletion Likely pathogenic rs1554329546 7:5568884-5568886 7:5529253-5529255
26 ACTB NM_001101.5(ACTB): c.527T> C (p.Leu176Pro) single nucleotide variant Likely pathogenic rs1554329331 7:5568187-5568187 7:5528556-5528556
27 ACTB NM_001101.5(ACTB): c.1013C> T (p.Ser338Phe) single nucleotide variant Likely pathogenic rs1554329113 7:5567494-5567494 7:5527863-5527863
28 ACTB NM_001101.5(ACTB): c.219C> G (p.His73Gln) single nucleotide variant Likely pathogenic 7:5568936-5568936 7:5529305-5529305
29 ACTB NM_001101.5(ACTB): c.64G> A (p.Ala22Thr) single nucleotide variant Likely pathogenic rs587780273 7:5569225-5569225 7:5529594-5529594
30 ACTB NM_001101.5(ACTB): c.19G> A (p.Ala7Thr) single nucleotide variant Likely pathogenic 7:5569270-5569270 7:5529639-5529639
31 ACTB NM_001101.5(ACTB): c.586C> T (p.Arg196Cys) single nucleotide variant Likely pathogenic rs281875333 7:5568128-5568128 7:5528497-5528497
32 ACTB NM_001101.5(ACTB): c.44G> C (p.Gly15Ala) single nucleotide variant Uncertain significance rs865913177 7:5569245-5569245 7:5529614-5529614
33 ACTB NM_001101.5(ACTB): c.686C> T (p.Thr229Met) single nucleotide variant Uncertain significance 7:5568028-5568028 7:5528397-5528397
34 ACTB NM_001101.5(ACTB): c.123+1G> A single nucleotide variant Uncertain significance rs794729643 7:5569165-5569165 7:5529534-5529534
35 ACTB NM_001101.5(ACTB): c.124-3C> T single nucleotide variant Uncertain significance 7:5569034-5569034 7:5529403-5529403
36 ACTB NM_001101.5(ACTB): c.1097dup (p.Ser368fs) duplication Uncertain significance rs1554329078 7:5567410-5567410 7:5527779-5527779
37 ACTB NM_001101.5(ACTB): c.307G> C (p.Val103Leu) single nucleotide variant Uncertain significance rs587779772 7:5568848-5568848 7:5529217-5529217
38 ACTB NM_001101.5(ACTB): c.882C> T (p.Tyr294=) single nucleotide variant Likely benign rs774758801 7:5567737-5567737 7:5528106-5528106
39 ACTB NM_001101.5(ACTB): c.669C> T (p.Phe223=) single nucleotide variant Likely benign rs369943480 7:5568045-5568045 7:5528414-5528414
40 ACTB NM_001101.5(ACTB): c.198C> T (p.Thr66=) single nucleotide variant Likely benign rs750565033 7:5568957-5568957 7:5529326-5529326
41 ACTB NM_001101.5(ACTB): c.1107C> T (p.Ile369=) single nucleotide variant Likely benign rs71531321 7:5567400-5567400 7:5527769-5527769
42 ACTB NM_001101.5(ACTB): c.474G> A (p.Gly158=) single nucleotide variant Likely benign rs141472083 7:5568240-5568240 7:5528609-5528609
43 ACTB NM_001101.5(ACTB): c.1011C> T (p.Tyr337=) single nucleotide variant Likely benign rs748194756 7:5567496-5567496 7:5527865-5527865
44 ACTB NM_001101.5(ACTB): c.264C> T (p.His88=) single nucleotide variant Likely benign rs574137728 7:5568891-5568891 7:5529260-5529260
45 ACTB NM_001101.5(ACTB): c.1044G> A (p.Ser348=) single nucleotide variant Benign/Likely benign rs13447409 7:5567463-5567463 7:5527832-5527832
46 ACTB NM_001101.5(ACTB): c.124-4C> T single nucleotide variant Benign/Likely benign rs13447397 7:5569035-5569035 7:5529404-5529404
47 ACTB NM_001101.5(ACTB): c.985-6C> T single nucleotide variant Benign rs182943508 7:5567528-5567528 7:5527897-5527897
48 ACTB NM_001101.5(ACTB): c.426G> T (p.Leu142=) single nucleotide variant Benign rs79074016 7:5568288-5568288 7:5528657-5528657
49 ACTB NM_001101.5(ACTB): c.903C> T (p.Gly301=) single nucleotide variant Benign rs13447407 7:5567716-5567716 7:5528085-5528085
50 ACTB NM_001101.5(ACTB): c.1023C> T (p.Ile341=) single nucleotide variant Benign rs58704474 7:5567484-5567484 7:5527853-5527853

UniProtKB/Swiss-Prot genetic disease variations for Baraitser-Winter Syndrome 1:

74
# Symbol AA change Variation ID SNP ID
1 ACTB p.Asn12Asp VAR_067810 rs281875331
2 ACTB p.Leu65Val VAR_067811 rs281875332
3 ACTB p.Arg196Cys VAR_067812 rs281875333
4 ACTB p.Arg196His VAR_067813 rs281875334

Expression for Baraitser-Winter Syndrome 1

Search GEO for disease gene expression data for Baraitser-Winter Syndrome 1.

Pathways for Baraitser-Winter Syndrome 1

GO Terms for Baraitser-Winter Syndrome 1

Sources for Baraitser-Winter Syndrome 1

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....